{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-031327","form_type":"8-K","ticker":"BIAF","cik":"0001712762","company_name":"bioAffinity Technologies, Inc.","filed_at":"2026-06-30T21:19:20+00:00","discovered_at":"2026-06-30T21:20:01.495076+00:00","generated_at":"2026-06-30T21:20:06.312487+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"bioAffinity reports 300% YoY CyPath Lung sales growth in April; partners with Philips for veteran screening","bullets":["CyPath Lung unit sales in April 2026 increased nearly 300% vs. April 2025; ordering physician sites up 69% Q1 2025 to Q1 2026.","Collaboration with Philips to enhance lung cancer screening for U.S. veterans using mobile CT, CyPath Lung, and 4DMedical software.","Pilot study with Brooke Army Medical Center underway for asthma/COPD companion diagnostics using flow cytometry+AI.","Preclinical research shows siRNA silencing selectively kills squamous skin cancer cells, suggesting topical treatment for basal/squamous cell carcinomas.","Recent news includes Mexico patent allowance for CyPath Lung technology and record monthly sales in April 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-031327","json":"https://secwatch.observer/filing/0001493152-26-031327.json","markdown":"https://secwatch.observer/filing/0001493152-26-031327.md","text":"https://secwatch.observer/filing/0001493152-26-031327.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226031327/0001493152-26-031327-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226031327/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T21:20:06.312487+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}